These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9432558)

  • 1. [Factors involved in gingival hyperplasia caused by diphenyl hydantoin].
    Mattioli A; Mauro S; Menetti L; Orlando S
    Minerva Stomatol; 1997 Oct; 46(10):525-32. PubMed ID: 9432558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dilantin gingival hyperplasia: patient evaluation in relation to anticonvulsant dosage, degree of oral hygiene and extension of lesion].
    Pugliesi NS; da Silva FT; Saleh ER; Biagini VS; Marin de los Rios C; Rode Sde M
    Rev Faculdade Odontol FZL; 1989; 1(2):97-103. PubMed ID: 2485648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reduction of phenytoin-induced gingival overgrowth in a severely disabled patient: a case report.
    Fitchie JG; Comer RW; Hanes PJ; Reeves GW
    Compendium; 1989 Jun; 10(6):314, 317-20. PubMed ID: 2605605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation.
    Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
    J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe phenytoin-induced gingival enlargement associated with periodontitis.
    Lucchesi JA; Cortelli SC; Rodrigues JA; Duarte PM
    Gen Dent; 2008; 56(2):199-203; quiz 204-5, 224. PubMed ID: 18348382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced gingival hyperplasia.
    Prescrire Int; 2011 Dec; 20(122):293-4. PubMed ID: 22216543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral hygiene status of epileptic patients under treatment with diphenyl hydantoin.
    Codipilly DP; Hoover JN
    Odontostomatol Trop; 1983 Dec; 6(4):223-7. PubMed ID: 6588372
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenytoin-induced gingival overgrowth control in severely retarded children.
    Steinberg SC; Steinberg AD
    J Periodontol; 1982 Jul; 53(7):429-33. PubMed ID: 6956708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hydantoin-induced hyperplasia].
    Korff M; Mutschelknauss R
    Dtsch Zahnarztl Z; 1973 Dec; 28(12):1157-63. PubMed ID: 4520580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents].
    Keglevich T; Benedek E; Gera I
    Fogorv Sz; 1999 Dec; 92(12):363-72. PubMed ID: 10641419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional aesthetic treatment of patient with phenytoin-induced gingival overgrowth.
    Luvizuto ER; da Silva JB; Campos N; Luvizuto GC; Poi WR; Panzarini SR
    J Craniofac Surg; 2012 May; 23(3):e174-6. PubMed ID: 22627422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
    Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F
    J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid and phenytoin induced gingival overgrowth--is there a preventive effect.
    Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
    J Indian Soc Pedod Prev Dent; 2004 Jun; 22(2):82-91. PubMed ID: 15491092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor oral hygiene enhances gingival overgrowth caused by calcineurin inhibitors.
    Reali L; Zuliani E; Gabutti L; Schönholzer C; Marone C
    J Clin Pharm Ther; 2009 Jun; 34(3):255-60. PubMed ID: 19646074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice.
    Thomason JM; Seymour RA; Rawlins MD
    Community Dent Oral Epidemiol; 1992 Oct; 20(5):288-91. PubMed ID: 1424550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
    Ball DE; McLaughlin WS; Seymour RA; Kamali F
    J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors in phenytoin-induced gingival hyperplasia.
    Addy V; McElnay JC; Eyre DG; Campbell N; D'Arcy PF
    J Periodontol; 1983 Jun; 54(6):373-7. PubMed ID: 6576127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral hygiene and dental pathology due to hydantoin].
    Weinstein R; Romeo E; Zandonella Necca S; Giuccioli D; Cornaggia C
    Prev Assist Dent; 1986; 12(4):7-11. PubMed ID: 3095818
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth.
    Yamada H; Nishimura F; Furuno K; Naruishi K; Kobayashi Y; Takashiba S; Murayama Y
    J Int Acad Periodontol; 2001 Apr; 3(2):42-7. PubMed ID: 12666977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tooth health, drugs, and gingival hyperplasia].
    Munthe-Kaas A; Storhaug K
    Tidsskr Nor Laegeforen; 1978 Jan; 98(3):161-2. PubMed ID: 628914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.